Lumenix today announced a groundbreaking multi-year collaboration agreement to deploy its Artificially Intelligent Monitoring System (AIMS) at the McGill University Health Centre (MUHC). The objective of this collaboration is to improve patient and staff safety, support workers, and contribute to the foundation for a personalized, inclusive, and innovative approach to healthcare delivery.
AIMS is an ambient sensing platform designed specifically for clinical use. Using a network of ceiling-embedded devices and infrared-based 3D sensors, the system anonymously perceives human behaviour and positioning, while remaining incapable of recognizing any personal information. AIMS delivers real-time, actionable intelligence that allows healthcare teams to proactively prevent adverse events, such as missed hand hygiene compliance, fall prevention and detection, and patient wandering, which leads to enhanced safety and improved patient outcomes.
This initiative supports the strategic vision of the IMPACT Centre (Initiatives and Methods for Partnerships, Analytics and Clinical Transformation), the MUHC’s AI Centre of Excellence, to accelerate the benefits derived from data and digital technologies. Central to that goal is the integration of novel technologies, such as AIMS, that can improve care outcomes at every stage of life.
The MUHC – Lumenix collaboration includes both the implementation of AIMS and the development of additional applications. These innovations will solve real clinical challenges providing immediate value to patient care and clinical staff at the MUHC, and create scalable solutions for healthcare systems worldwide.
AIMS has been clinically validated through multiple deployments and clinical trials, including a successful comprehensive clinical trial led by the Government of Canada. AIMS’ hand hygiene application has delivered sustained improvement in hand hygiene compliance and significantly reduced outbreaks.
The MUHC – Lumenix collaboration is an investment in the future of healthcare and creates a model for how healthcare systems can advance technology through innovation, shared values and teamwork.
Related
This entry was posted on September 3, 2025 at 12:48 pm and is filed under Commentary with tags Lumenix. You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
Lumenix and McGill University Health Centre Collaborate to Enhance Patient Safety and Support Care Staff Using Ambient Perception-Action AI Platform Technology
Lumenix today announced a groundbreaking multi-year collaboration agreement to deploy its Artificially Intelligent Monitoring System (AIMS) at the McGill University Health Centre (MUHC). The objective of this collaboration is to improve patient and staff safety, support workers, and contribute to the foundation for a personalized, inclusive, and innovative approach to healthcare delivery.
AIMS is an ambient sensing platform designed specifically for clinical use. Using a network of ceiling-embedded devices and infrared-based 3D sensors, the system anonymously perceives human behaviour and positioning, while remaining incapable of recognizing any personal information. AIMS delivers real-time, actionable intelligence that allows healthcare teams to proactively prevent adverse events, such as missed hand hygiene compliance, fall prevention and detection, and patient wandering, which leads to enhanced safety and improved patient outcomes.
This initiative supports the strategic vision of the IMPACT Centre (Initiatives and Methods for Partnerships, Analytics and Clinical Transformation), the MUHC’s AI Centre of Excellence, to accelerate the benefits derived from data and digital technologies. Central to that goal is the integration of novel technologies, such as AIMS, that can improve care outcomes at every stage of life.
The MUHC – Lumenix collaboration includes both the implementation of AIMS and the development of additional applications. These innovations will solve real clinical challenges providing immediate value to patient care and clinical staff at the MUHC, and create scalable solutions for healthcare systems worldwide.
AIMS has been clinically validated through multiple deployments and clinical trials, including a successful comprehensive clinical trial led by the Government of Canada. AIMS’ hand hygiene application has delivered sustained improvement in hand hygiene compliance and significantly reduced outbreaks.
The MUHC – Lumenix collaboration is an investment in the future of healthcare and creates a model for how healthcare systems can advance technology through innovation, shared values and teamwork.
Share this:
Like this:
Related
This entry was posted on September 3, 2025 at 12:48 pm and is filed under Commentary with tags Lumenix. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.